COURTNEY MARCOTTE: Open Payments
NPI 1861947962 · ALBION, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 31 payments from 12 companies in 2025. Trend: 2023 $1,033 · 2024 $739 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $199 |
| ABBVIE INC. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| PFIZER INC. | 3 | $54 |
| Lundbeck LLC | 2 | $49 |
| Novo Nordisk Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: REXULTI, FARXIGA, QULIPTA, BREZTRI, NURTEC ODT, Ozempic, AIRSUPRA, MOUNJARO.
Industry payments across ME — which companies pay providers there.
